JOINT FILING AGREEMENT
Exhibit 99.1
In accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including additional amendments thereto) with respect to the common stock, par value $0.0001 per share, of Praxis Precision Medicines, Inc., a Delaware corporation. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.
Dated: March 20, 2023
| Velan Capital Master Fund LP | |||
| By: | Velan Capital Holdings LLC General Partner | ||
| By: |
/s/ Xxxx Xxxxxx | ||
| Name: | Xxxx Xxxxxx | ||
| Title: | Managing Member | ||
| Velan Capital Holdings LLC | |||
| By: |
/s/ Xxxx Xxxxxx | ||
| Name: | Xxxx Xxxxxx | ||
| Title: | Managing Member | ||
| Velan Capital Investment Management LP | |||
| By: | Velan Capital Management LLC General Partner | ||
| By: |
/s/ Xxxx Xxxxxx | ||
| Name: | Xxxx Xxxxxx | ||
| Title: | Managing Member | ||
| Velan Capital Management LLC | |||
| By: |
/s/ Xxxx Xxxxxx | ||
| Name: | Xxxx Xxxxxx | ||
| Title: | Managing Member | ||
|
/s/ Xxxx Xxxxxx | |
| Xxxx Xxxxxx |
|
/s/ Xxxxxx Xxxxxxxxxxxx | |
| Xxxxxx Xxxxxxxxxxxx |
